1. Home
  2. SGMO vs BDSX Comparison

SGMO vs BDSX Comparison

Compare SGMO & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.26

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$13.34

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGMO
BDSX
Founded
1995
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.2M
122.0M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
SGMO
BDSX
Price
$0.26
$13.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$7.00
$32.50
AVG Volume (30 Days)
7.4M
60.8K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
10.20
N/A
EPS
N/A
N/A
Revenue
$36,567,000.00
$88,499,000.00
Revenue This Year
$24.46
$25.26
Revenue Next Year
$193.67
$19.70
P/E Ratio
N/A
N/A
Revenue Growth
88.60
24.08
52 Week Low
$0.21
$0.25
52 Week High
$0.84
$20.21

Technical Indicators

Market Signals
Indicator
SGMO
BDSX
Relative Strength Index (RSI) 35.23 39.83
Support Level $0.21 $6.33
Resistance Level $0.55 $20.21
Average True Range (ATR) 0.04 1.12
MACD -0.00 -0.34
Stochastic Oscillator 25.91 11.46

Price Performance

Historical Comparison
SGMO
BDSX

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: